First Horizon Advisors, Inc. Exact Sciences Corp Transaction History

First Horizon Advisors, Inc.

  • $3.81 Billion
  • Q2 2025

A detailed history of First Horizon Advisors, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 966 shares of EXAS stock, worth $64,750. This represents 0.0% of its overall portfolio holdings.

Number of Shares
966
Previous 1,512 36.11%
Holding current value
$64,750
Previous $65,000 21.54%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 05, 2025
SELL
$40.31 - $58.08 $22,009 - $31,711
-546 Reduced 36.11%
966 $51,000
Q1 2025

Apr 28, 2025
SELL
$43.04 - $58.51 $19,712 - $26,797
-458 Reduced 23.25%
1,512 $65,000
Q4 2024

Feb 03, 2025
SELL
$49.33 - $71.97 $24,763 - $36,128
-502 Reduced 20.31%
1,970 $110,000
Q3 2024

Nov 08, 2024
BUY
$42.43 - $70.83 $1,909 - $3,187
45 Added 1.85%
2,472 $168,000
Q2 2024

Jul 19, 2024
SELL
$41.33 - $74.26 $7,067 - $12,698
-171 Reduced 6.58%
2,427 $102,000
Q1 2024

Apr 26, 2024
SELL
$56.27 - $73.77 $4,839 - $6,344
-86 Reduced 3.2%
2,598 $179,000
Q4 2023

Feb 06, 2024
BUY
$59.06 - $75.72 $3,248 - $4,164
55 Added 2.09%
2,684 $198,000
Q3 2023

Oct 27, 2023
SELL
$65.94 - $99.04 $27,496 - $41,299
-417 Reduced 13.69%
2,629 $179,000
Q2 2023

Aug 03, 2023
SELL
$62.68 - $95.05 $92,829 - $140,769
-1,481 Reduced 32.71%
3,046 $286,000
Q1 2023

May 15, 2023
SELL
$47.19 - $70.77 $73,569 - $110,330
-1,559 Reduced 25.62%
4,527 $306,000
Q4 2022

Feb 10, 2023
BUY
$30.35 - $53.15 $13,536 - $23,704
446 Added 7.91%
6,086 $301,000
Q3 2022

Nov 09, 2022
BUY
$31.97 - $49.37 $13,203 - $20,389
413 Added 7.9%
5,640 $182,000
Q2 2022

Aug 02, 2022
BUY
$35.61 - $76.23 $170,287 - $364,531
4,782 Added 1074.61%
5,227 $205,000
Q1 2022

May 10, 2022
SELL
$57.56 - $82.54 $119,782 - $171,765
-2,081 Reduced 82.38%
445 $31,000
Q4 2021

Feb 09, 2022
BUY
$72.5 - $100.68 $17,327 - $24,062
239 Added 10.45%
2,526 $196,000
Q3 2021

Nov 15, 2021
SELL
$90.24 - $124.05 $680,138 - $934,964
-7,537 Reduced 76.72%
2,287 $218,000
Q3 2021

Nov 09, 2021
BUY
$90.24 - $124.05 $700,262 - $962,628
7,760 Added 375.97%
9,824 $937,000
Q2 2021

Aug 09, 2021
BUY
$93.66 - $139.27 $91,318 - $135,788
975 Added 89.53%
2,064 $256,000
Q1 2021

May 11, 2021
BUY
$116.57 - $155.01 $80,316 - $106,801
689 Added 172.25%
1,089 $143,000
Q2 2020

Jul 31, 2020
BUY
$55.75 - $92.75 $12,934 - $21,518
232 Added 138.1%
400 $34,000
Q1 2020

May 05, 2020
SELL
$37.9 - $104.44 $2,653 - $7,310
-70 Reduced 29.41%
168 $9,000
Q4 2019

Jan 07, 2020
BUY
$77.66 - $99.74 $5,436 - $6,981
70 Added 41.67%
238 $22,000
Q3 2019

Oct 23, 2019
SELL
$90.37 - $122.49 $6,325 - $8,574
-70 Reduced 29.41%
168 $15,000
Q1 2019

Apr 26, 2019
BUY
$61.98 - $96.5 $14,751 - $22,967
238 New
238 $0

Others Institutions Holding EXAS

# of Institutions
672
Shares Held
164M
Call Options Held
2.2M
Put Options Held
1.69M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email